systematic_review
    2005
    High Quality

    Milk thistle for alcoholic and/or hepatitis B or C liver diseases: a systematic Cochrane Hepato-Biliary Group review with meta-analyses of randomized clinical trials

    Rambaldi A, Jacobs BP, Gluud C

    Published in American Journal of Gastroenterology

    Key Findings

    Milk thistle did not significantly influence mortality, complications or liver histology; apparent benefits disappeared in high-quality trials.

    Conclusions

    No convincing benefit in chronic liver disease.

    Limitations

    Trial quality generally low.

    Supplements Studied

    Milk thistle did not significantly influence mortality, complications or liver histology in chronic liver disease.

    Outcomes Measured

    Liver Protection

    Milk thistle did not significantly influence mortality, complications or liver histology.

    Related Health Concerns

    Non-Alcoholic Fatty Liver Disease

    Study Details

    Year:2005
    Sample Size:1,088
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.